According to a newly published market research report by 24LifeSciences, Global Lenvatinib Mesylate Capsules Market was valued at USD 1.3 billion in 2024 and is projected to reach USD 2.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 20252032. Lenvatinib Mesylate, commercially known as Lenvima, is a multi-kinase inhibitor specifically...